OAR@UM: Browsing OAR@UM

Browsing by Author Serracino-Inglott, Anthony

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 365 to 384 of 460 < previous next >

Issue Date	Title	Author(s)
2022	QT shortening : a proarrhythmic safety surrogate measure or an inappropriate indicator of it?	Tanti, Amy; Micallef, Benjamin; Vella Szijj, Janis; Serracino-Inglott, Anthony; Borg, John-Joseph
2014-03	A qualitative and quantitative method for difluprednate using high performance liquid chromatography	Sammut Bartolo, Nicolette; Vella, Janis; Serracino-Inglott, Anthony; Ferrito, Victor; Azzopardi, Lilian M.
2012-03	Quality improvements in good distribution practice	Buttigieg, Suzanne; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2018	Quality issues identified during the evaluation of biosimilars by the european medicines agency’s committee for medicinal products for human use	Cilia, Mark; Ruiz, Sol; Richardson, Peter; Salmonson, Tomas; Serracino-Inglott, Anthony; Wirth, Francesca; Borg, John-Joseph
2013-08	Quality management system for non-clinical pharmacy services at a rehabilitation hospital	Agius, John; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2012-09	Quality of life in hypertensive dialysis patients	Mercieca, Anne Marie; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2014	Quality risk management implementation for a medicinal products wholesale dealer	Busuttil, Adrian; Serracino-Inglott, Anthony
2018-11	Rare diseases and orphan drug availability in Malta	Abbas, Amar; Vella Szijj, Janis; Serracino-Inglott, Anthony
2021	Rare diseases and orphan medicines	Vassallo, Sharon; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony
2022	Rare diseases and orphan medicines : knowledge and perceptions of healthcare professionals and the public	Vassallo, Sharon; Attard Pizzuto, Maresca; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2018-09	Reaching concordance in community pharmacy regulatory audits	Attard, Annalise; Wirth, Francesca; Serracino-Inglott, Anthony
2022	Reflections on the use of cannabidiol for medicinal purposes and the views of healthcare professionals	Calleja, Abigail; Vella Szijj, Janis; Serracino-Inglott, Anthony
2020	Regulation of medical devices in Europe and Africa	Dusabe, Gloria; Serracino-Inglott, Anthony
2021	Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EU	Butler, Dianne; Vucic, Katarina; Straus, Sabine; Cupelli, Amelia; Micallef, Benjamin; Serracino-Inglott, Anthony; Borg, John-Joseph
2019	Regulatory sciences and translational pharmacogenetics : amitriptyline as a case in point	Mifsud Buhagiar, Luana; Micallef, Benjamin; Borg, John-Joseph; Vella, Helen; Serracino-Inglott, Anthony; LaFerla, Godfrey
2012-10	Responding to urinary tract infections during pregnancy in community pharmacy	Busuttil, Katya; Azzopardi, Lilian M.; Serracino-Inglott, Anthony
2016-10	Retrospective analysis of serum digoxin concentrations at Mater Dei Hospital	Vella, John; Wirth, Francesca; Xuereb, Robert G.; Barbara, Christopher; Zarb Adami, Maurice; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2021	Review of methods for TPMT biomarker genotyping in the personalisation of thiopurine therapy	Camilleri, Leanne; Wirth, Francesca; Serracino-Inglott, Anthony; Azzopardi, Lilian M.
2018	A review of the national adverse drug reaction (ADR) & medication errors reporting system of Malta	Borg, John-Joseph; Serracino-Inglott, Anthony; Al-Haddad, Dania
2021	Risk assessment in pharmaceutical processes	Bezzina, Abigail; Attard Pizzuto, Maresca; Serracino-Inglott, Anthony; Azzopardi, Lilian M.

Showing results 365 to 384 of 460 < previous next >